Next Article in Journal
Somatic Marker Production Deficits Do Not Explain the Relationship between Psychopathic Traits and Utilitarian Moral Decision Making
Next Article in Special Issue
Kappa Free Light Chains and IgG Combined in a Novel Algorithm for the Detection of Multiple Sclerosis
Previous Article in Journal
Deep Brain Stimulation for Gilles de la Tourette Syndrome: Toward Limbic Targets
Previous Article in Special Issue
The Long Road of Immunotherapeutics against Multiple Sclerosis
Review

Molecular Interventions towards Multiple Sclerosis Treatment

1
Institute of Molecular Biology and Biotechnology, Foundation for Research and Technology Hellas, Nikolaou Plastira 100, 70013 Heraklion, Greece
2
Department of Basic Sciences, Faculty of Medicine, University of Crete, 71110 Heraklion, Greece
*
Author to whom correspondence should be addressed.
Received: 28 April 2020 / Revised: 11 May 2020 / Accepted: 12 May 2020 / Published: 15 May 2020
(This article belongs to the Special Issue Advances in Multiple Sclerosis Research—Series I)
Multiple sclerosis (MS) is an autoimmune life-threatening disease, afflicting millions of people worldwide. Although the disease is non-curable, considerable therapeutic advances have been achieved through molecular immunotherapeutic approaches, such as peptides vaccination, administration of monoclonal antibodies, and immunogenic copolymers. The main aims of these therapeutic strategies are to shift the MS-related autoimmune response towards a non-inflammatory T helper 2 (Th2) cells response, inactivate or ameliorate cytotoxic autoreactive T cells, induce secretion of anti-inflammatory cytokines, and inhibit recruitment of autoreactive lymphocytes to the central nervous system (CNS). These approaches can efficiently treat autoimmune encephalomyelitis (EAE), an essential system to study MS in animals, but they can only partially inhibit disease progress in humans. Nevertheless, modern immunotherapeutic techniques remain the most promising tools for the development of safe MS treatments, specifically targeting the cellular factors that trigger the initiation of the disease. View Full-Text
Keywords: B cell receptor; delivery methods; immunotherapy; monoclonal antibodies; multiple sclerosis; T cell receptor; tolerance; vaccine B cell receptor; delivery methods; immunotherapy; monoclonal antibodies; multiple sclerosis; T cell receptor; tolerance; vaccine
Show Figures

Graphical abstract

MDPI and ACS Style

Metaxakis, A.; Petratou, D.; Tavernarakis, N. Molecular Interventions towards Multiple Sclerosis Treatment. Brain Sci. 2020, 10, 299. https://0-doi-org.brum.beds.ac.uk/10.3390/brainsci10050299

AMA Style

Metaxakis A, Petratou D, Tavernarakis N. Molecular Interventions towards Multiple Sclerosis Treatment. Brain Sciences. 2020; 10(5):299. https://0-doi-org.brum.beds.ac.uk/10.3390/brainsci10050299

Chicago/Turabian Style

Metaxakis, Athanasios, Dionysia Petratou, and Nektarios Tavernarakis. 2020. "Molecular Interventions towards Multiple Sclerosis Treatment" Brain Sciences 10, no. 5: 299. https://0-doi-org.brum.beds.ac.uk/10.3390/brainsci10050299

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop